Centene is trading at $64.30, with a -4.02% change as investors may be reassessing enrollment and cost concerns.
- The decline reverses part of the 4.56% gain on August 5.
- No fresh August 6 company announcement or analyst action was identified; concerns were previously highlighted after the strong second-quarter report, despite raised guidance.
- Healthcare is rising 1.31%, so sector strength does not explain Centeneβs decline.